Interaction between valproic acid and meropenem: Description of two pediatric cases;Interacción entre ácido valproico y meropenem: Descripción de dos casos infantiles

Atencion Farmaceutica

Volumn 10, Issue 2, 2008, Pages 121-124

  Sanchez Martinez I ^a   Flores Gonzalez C ^a   Hernandez Gonzalez A ^a   Macarena Ley Martos, M ^a   Lubian Lopez S ^a   Benavides Medina, M T ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Children; Epilepsy; Meropenem; Pharmacokinetic interaction; Plasmatic concentrations; Valproic acid

Indexed keywords

AMIKACIN; CEFTAZIDIME; CLONAZEPAM; DIAZEPAM; MEROPENEM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONVULSION; DRUG BLOOD LEVEL; DRUG EFFICACY; EPILEPSY; FEMALE; HUMAN; MALE; NEWBORN; RISK ASSESSMENT;

EID: 46749152585     PISSN: 11397357     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Meropenem®. Resumen de las características del producto.
2. Depakine®. Resumen de las características del producto.
3. Spriet I, Goyens J, Meersseman W, Wilmer A, Willems L, Van Paesschen W. Interaction between valproate and meropenem: a retrospective study. Ann Pharmacother 2007; 41: 1130-6.
4. Spriet I, Meersseman W, De Troy E, Wilmer A, Casteels M, Willems L. Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus. Am J Health Syst Pharm. 2007; 64: 54-8.
5. De Turck BJ, Diltoer MW, Cornelis PJ, Maes V, Spapen HD, Camu F et al. Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin. J Antimicrob Chemother 1998; 42: 563-4.
6. Horiuchi M, Kimura M, Tokumura M, Hasebe N, Arai T, Abe K. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics. Toxicology 2006; 222: 114-24.
7. Valproic Acid. MICROMEDEX (R) Healthcare Series 1974-20. (Consultado: 09/09/2007).
8. Nakajima Y, Mizobuchi M, Nakamura M, Takagi H, Inagaki H, Kominami G et al. Mechanism of the drug interaction between valproic acid and carbapenem antibiotics in monkeys and rats. Drug Metab Dispos 2004; 32: 1383-91.
9. Yokogawa K, Iwashita S, Kubota A, Sasaki Y, Ishizaki J, Kawahara M et al. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits. Pharm Res 2001; 18: 1320-6.
10. Fudio S, Carcas A, Pinana E, Ortega R. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. J Clin Pharm Ther 2006; 31: 393-6.
11. Hirata-Koizumi M, Saito M, Miyake S, Hasegawa R. Adverse events caused by drug interactions involving glucuronoconjugates of zidovudine, valproic acid and lamotrigine, and analysis of how such potential events are discussed in package inserts of Japan, UK and USA. J Clin Pharm Ther 2007; 32: 177-85.
12. Coves FJ, Borras J, Navarro A, Murcia A, Palacios F. Acute seizures due to a probable interaction between valproic acid and meropenem. Ann Pharmacother 2005; 39: 533-7.
13. Clause D, Decleire PY, Vanbinst R, Soyer A, Hantson P. Pharmacokinetic interaction between valproic acid and meropenem. Intensive Care Med 2005; 31: 1293-4.
14. Perez A, Soy D, Nicolas JM. Pharmacokinetic interaction between valproic acid and meropenem. Med Clin (Bare) 2004; 123: 38-9.
15. Llinares F, Bosacoma N, Hernández C, Climent E, Selva J, Ordovás JP. Interacción farmacocinética entre ácido valproico y antibióticos carbapenémicos: descripción de tres casos. Farm Hosp 2003; 27: 258-63.
16. Nacarkucuk E, Saglam H, Okan M. Meropenem decreases serum level of Valproic Acid. Pediatr Neurol 2004; 31: 232-4.
17. Sala F, Padulles N, Hidalgo E, Clemente S, Cabanas MJ, Oliveras M et al. Pharmacokinetic interaction between valproic acid and meropenem. Ann Pediatr 2006; 64: 93-5.
18. Santucci M, Parmeggiani A, Riva R. Seizure worsening caused by decreased serum valproate during meropenem therapy. J Child Neurol 2005; 20: 456-7.